Clinical Trial Results: Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and tolerability study of aripiprazole in children and adolescents with schizophrenia or mania completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mania
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Mania | Phase 1 | Status: COMPLETED | Results posted: 2026-06-22